CellMark Highlights 1990

Our extensive story stretches 35 years back in time. Follow us on a journey through our history. Discover more about our highlights, network, our specialists and the long lasting relationships we build together with our industry partners for the future. The next milestone is 1990 – expanding our global footprint.

 

1990

CellMark reach the 1 million ton mark and sell products in 36 markets.

Today we handle a volume close to 7 million tons and have a global footprint in more than 120 markets.

 

Find our more about our sales and marketing services here.

 

 

Read more

CellMark Highlights 1987

Our extensive story stretches 35 years back in time. Follow us on a journey through our history. Discover more about our highlights, network, our specialists and the long lasting relationships we build together with our industry partners. The next milestone is 1987 – a growth strategy begins to take shape.

 

1987

We acquire Pacific Forest Resources Inc (PacFor), adding packaging paper and board as well as recovered paper to our existing base in market pulp and whitepaper.

Today we run 7 successful international divisions.

 

Find our more about our divisions and business units here.

 

 

Read more

CellMark Highlights year 1987

Our extensive story stretches 35 years back in time. Follow us on a journey through our history. Discover more about our highlights, network, our specialists and the long lasting relationships we build together with our industry partners. The second milestone in 1987 relates to our owners, who also work here!

 

1987

CellMark was founded with the idea of having employees as main owners. This year 1987, CellMark become 100% employee owned.

And still today, we are a privatey held independent supply chain service company owned by its employees and an outside corner investor, Ernström & Co.

 

Find our more about our people here.

 

Read more

Sensus Healthcare Inc – a new Partnership for CellMark Medical this summer

Sensus Healthcare a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers and keloids with superficial radiation therapy (SRT), and CellMark Medical, a global supply chain service company, today announced a new partnership to support and accelerate international growth and encourage worldwide adoption of Sensus’ groundbreaking technologies for oncological and aesthetic indications.

Extracted from the news provided by Sensus Healthcare:

“CellMark Medical was formed to create a pathway for domestically successful, innovative medical technologies to expand from their home markets into emerging geographic locations around the world,” said Oliver Moorhouse, Head of the Americas, CellMark Medical. “As the preference is to focus on underserved clinical areas, such as skin cancer and keloids, we view Sensus Healthcare as a partner for life, and the opportunity to expedite and sustain this global growth is truly a privilege. Achieving inaugural solution commitments in international markets within six months of launching speaks volumes for the collaboration that we have developed with the Sensus management team.”

The collaboration aims to facilitate timely access for patients all over the world to Sensus’ extensive portfolio of aesthetic and dermatology solutions, including SRT and Sensus Laser Systems, as well as the Company’s future oncology solutions. CellMark Medical will leverage its proprietary trading platform and healthcare industry networks to develop sales and distribution channels in global markets, as well as work with new and existing sales partners to facilitate effective cross-border supply chain operations.

Following Sensus’ distribution deals earlier this year in ChinaMexico and Thailand, among others, Sensus Healthcare and CellMark Medical will now focus on expanding distribution to JapanSoutheast Asia, Central and South Americaand Canada. The partnership has already led to the successful order of the first SRT-100 solution in Vietnam by Dr. Vu Quang Vinh, Head of the Department of Plastic and Aesthetic Reconstructive Surgery at the National Hospital of Burns in Ha Noi.

“Sensus’ collaboration with CellMark Medical offers a critical boost of support to Sensus’ international business development, which is a key priority for the Company this year,” added Rick Golin, Sensus Healthcare Executive Vice President of International Sales. “Combining Sensus’ expertise in aesthetic and dermatological solutions with CellMark Medical’s product shipping, warehousing, financing, market-specific experience and worldwide user / distributor digital CMDS system enables wider, more efficient global reach, ultimately helping to bring Sensus’ transformative technology to more patients in need all over the world.”

Read PS Newswire’s full pressrelase here.

 

Read more

They’re Finally Here – Our Summer Heroes

The start of the summer holidays is here and we welcome this year’s summer workers to CellMark head office in Gothenburg!

During the summer months July and August, ten ambitious students have chosen to spend their summer, gaining some work experience, within their future professions. These young people, of whom many are local students from Gothenburg University, bring a range of new skills to our company. We are happy to have them here with us, holding down the fort during the summer holiday.

Thank you all for doing a great job!

 
Read more

CellMark Highlights 1984

Our extensive story stretches 35 years back in time. Follow us on a journey through our history. Discover more about our highlights, network, our specialists and the long lasting relationships we build together with our industry partners. The first milestone is 1984 – the year when it all began.

 

1984

CellMark is founded in Gothenburg with 21 employees, as an international pulp and paper marketing company with a goal to demonstrate a new marketing alternative.

Today we are 700+ employees, in 65+ offices worldwide.

 

Find our more about our global presence and network here.

 

 

Read more
Copyright CellMark AB General trade rules Certifications Privacy Policy Tax Policy GDPR Rights
This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Review our legal notice and privacy policy for more details. close